Doctor profile · Federal record

Dr. Prashanth Palwai, MD

Rheumatology Physician (CMS: Rheumatology) · Kingwood, TX

  • NPI 1225071855
  • Accepts Medicare
  • MIPS 63.6 / 100 · 2023
  • 33 yrs in practice
  • Male
  • Solo practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
22999 Highway 59 N, Suite 230
Kingwood, TX 773394412
(281) 319-4700
Mailing address
Po Box 8455
The Woodlands, TX 773878455

Credentials & registration

NPPES · NUCC
NPI registered
June 2006 — 20 yrs on file
Profile last updated
February 28, 2014
Year of graduation
1993 — 33 yrs since
Specialty taxonomy
207RR0500X — NUCC code
State license (1)
Texas #L 9414

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1225071855. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
105,177
Distinct HCPCS
10
Medicare allowed
$1,039,836
HCPCS Description Services Patients Avg allowed
J0717 Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) 90,400 32 $5
J0129 Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) 9,375 20 $42
J1745 Injection, infliximab, excludes biosimilar, 10 mg 3,460 12 $33
96372 Injection of drug or substance under skin or into muscle 472 41 $14
J7050 Infusion, normal saline solution, 250 cc 402 37 $1
99214 Established patient office or other outpatient visit, 30-39 minutes 334 193 $123
96361 Infusion into a vein for hydration, each additional hour 198 36 $12
J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg 138 27 $1
96365 Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less 108 20 $61
96413 Administration of chemotherapy into vein, 1 hour or less 96 27 $125

In context: peer comparison

Among 2 peers in Kingwood Rheumatology Physician, average services per provider: 6,197. This provider delivers 17× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$145
Transactions
2
Manufacturers
2
Payer (manufacturer) Industry Txns Amount
AstraZeneca Pharmaceuticals Lp 1 $118.19
Abbvie INC. 1 $26.69

By nature of payment

Food and Beverage
$145

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
591
Patients
229
Total drug cost
$255,692
Drug Type Claims Patients Total cost
Hydroxychloroquine Sulfate Generic 167 64 $11,363
Methotrexate (Methotrexate Sodium) Brand 116 52 $5,761
Leflunomide Generic 86 41 $5,627
Gabapentin Generic 46 17 $1,586
Methylprednisolone Generic 44 34 $388
Prednisone Generic 44 21 $189
Sulfasalazine Generic 30 0 $696
Humira(Cf) Pen (Adalimumab) Brand 23 0 $229,424
Azathioprine Generic 18 0 $569
Folic Acid Generic 17 0 $88

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Prashanth Palwai's medical specialty?
Dr. Prashanth Palwai practices Rheumatology Physician in Kingwood, TX.
Where does Dr. Prashanth Palwai practice?
Dr. Prashanth Palwai practices at 22999 Highway 59 N, Kingwood, TX 773394412. Office phone: 2813194700.
What is Dr. Prashanth Palwai's NPI?
Dr. Prashanth Palwai's National Provider Identifier (NPI) is 1225071855, issued by NPPES.
Does Dr. Prashanth Palwai accept Medicare assignment?
Yes. Dr. Prashanth Palwai accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Prashanth Palwai commonly perform?
Top Medicare-reported procedures in 2023: Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0717); Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) (HCPCS J0129); Injection, infliximab, excludes biosimilar, 10 mg (HCPCS J1745). Source: CMS Medicare Physician & Other Practitioners file.